HPV PREVENTION RESOURCES

An estimated 72,454 incident diagnoses of genital HPV infection occurred between 2007-2016 among active component U.S. service members (rate of 60.1 cases per 100,000 person years) (MSMR. 2017 Vol24, No9)

Facts

• Navy HPV Vaccination Video (NMCPHC-SHARP; 2014)
• Sexual Health Quickie - HPV Vaccination (NMCPHC-SHARP 2017). Stream now (CaC required)
• Vaccine Information Sheet - Gardasil®-9 (ACIP)
• Poster - HPV Vaccine (NMCPHC)
• HPV Vaccine Information Sheet for Young Women (CDC)
• HPV Vaccine Information Sheet for Parents (CDC)
•  
• HPV and HPV Vaccines (CDC)
•  

For Clinicians

• BUMED HPV Vaccination Policy
• Healthcare Provider - You are the Key (CDC)
•  
• Voluntary Recall of One Lot of Gardasil HPV Vaccine (CDC; 20 Dec 2013)
• ACIP Recommendations: 9 Valent HPV Vaccine
• ACIP Recommendations
• HPV Vaccination for Boys and Men (MMWR; Dec 23 2012)
• Gardasil Vaccine Information Sheet (HPV4)
•  

HPV Prevalence and Vaccination Data

• Surveillance snapshot: Human papillomavirus vaccination among U.S. active component service members in the Millennium Cohort Study, 2006–2017; June 2019; AFMSC MSMR 26;6
• Human Papillomavirus Vaccine Initiation, Coverage, and Completion Rates Among U.S. Active Component Service Members, 2007–2017; September 2018; AFMSC MSMR 25;9:9
• Prevalence of HPV in Adults Aged 18–69: United States, 2011–2014 (CDC)
• CDC recommends only two HPV shots for younger adolescents (press release Oct 2016)
• Use of Quadrivalent Human Papillomavirus Vaccine and the Prevalence of Antibodies to Vaccine-targeted Strains Among Female Service Members Before and After Vaccination AFHSC (2016). MSMR 23;2:6
• Quadrivalent human papillomavirus vaccine initiation, coverage, and compliance among U.S. active component service women, 2006-2011 (MSMR May 2012;19(5)16)
• Human papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service(MSMR. Feb 2013; Vol 20: No 2)
• Genital Warts Among U.S. Service Members Before and After the Introduction of the Quadrivalent Human Papillomavirus Vaccine (MSMR. Feb 2013; Vol 20: No 2)